Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001104659-23-009972

Chief Financial Officer acquired 1,172 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Eisenstadt Richard I Chief Financial Officer 2023-01-31 Grant or award +1,172 $10.21 $11,964 12,010 D: show line 1 in the form
Loading xslF345X03/tm235311-1_4seq1.xml…